Arvind Gupta has been appointed as General Manager – Quality Assurance at Amneal Pharmaceuticals, marking a significant step in his leadership journey within the pharmaceutical quality domain. Based in Hyderabad, Gupta will now serve as the Site Quality Head at Amneal’s Onco Injectable Facility, which operates with cutting-edge Isolator Technology and is approved by key global regulators including USFDA and EU-GMP authorities.
With nearly five years of dedicated service at Amneal Pharmaceuticals, Gupta has steadily risen through the ranks, having previously served as Deputy General Manager and Assistant General Manager, where he played an instrumental role in strengthening quality compliance and regulatory readiness across manufacturing operations. His deep expertise in injectables, regulatory frameworks, and plant quality systems positions him well to lead the site’s strategic quality roadmap in alignment with global standards.
Gupta’s role as the site head comes at a pivotal time for Amneal, as the company continues to expand its oncology pipeline and deliver high-quality, affordable treatments to global markets. His mandate includes overseeing all quality assurance functions, ensuring data integrity, and fostering a culture of continuous improvement through Lean Six Sigma methodologies—areas where Gupta holds certified expertise, as recognized through his credentials from LinkedIn Learning in Six Sigma Foundations, Define and Measure Tools, and Communication Foundations.
As a key leader in Amneal’s quality ecosystem, Gupta is expected to drive excellence across product lifecycle management, regulatory inspections, and cross-functional quality initiatives. His elevation reaffirms Amneal Pharmaceuticals’ commitment to nurturing internal talent and reinforcing its strong compliance culture across facilities worldwide. With a steady hand and sharp technical acumen, Gupta is poised to elevate Amneal’s quality benchmarks even further.
His appointment underscores the company’s mission to deliver safe, effective, and innovative therapies—anchored in quality leadership and operational integrity. As Amneal continues to scale its injectable offerings, Arvind Gupta’s leadership will be central to ensuring the facility not only meets but exceeds global expectations.